)
Edge3 Oct 2025
Epiroc: A Culture of Moving Mountains
From automation to electrification, Swedish industrial giant Epiroc is leading a transformation in how the world mines.
Camurus (CAMX) investor relations material
Camurus Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2025 earnings summary17 Jul, 2025
Executive summary
Achieved record Q2 2025 revenues of SEK 676 million, up 52% year-over-year, and profit before tax of SEK 307 million, up 195% year-over-year.
Cash position strengthened to SEK 3.3 billion at quarter-end, a 30% increase year-over-year, supporting expansion and R&D investments.
Entered a strategic license agreement with Eli Lilly for long-acting incretins, with up to USD 870 million in milestones and royalties.
EU approval of Oczyesa (CAM2029) for acromegaly and positive results from key clinical studies, including polycystic liver disease.
Buvidal and Brixadi drove growth, with market share gains and expansion into new regions.
Financial highlights
Q2 2025 revenues: SEK 676 million (+52% year-over-year); H1 2025: SEK 1,234 million (+48%).
Profit before tax for Q2: SEK 307 million (+195%); margin at 45.4%.
Earnings per share after dilution for Q2: SEK 4.08; profit after tax: SEK 245 million.
Gross margin for Q2: 93.9%, up 106 bps year-over-year.
Cash flow from operating activities in Q2: SEK 376 million; cash position at quarter-end: SEK 3.35 billion.
Outlook and guidance
2025 guidance maintained: total revenues SEK 2.7–3.0 billion (+45–61% vs. 2024), profit before tax SEK 0.9–1.2 billion (+63–117%).
Growth expected in H2, with Buvidal and Brixadi benefiting from improved funding and market access.
Continued investments in R&D and US operations, including SEK 0.35 billion for global CAM2029 launch.
Assess Oczyesa's EU launch preparations.
Explain Brixadi's renewed US growth.
What's the CAM2056 Phase 1 study progress?
What's the timeline for CAM2029 Phase III in PLD?
What factors drive Buvidal's growth in new markets?
How will Medicaid changes impact OUD treatment?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Camurus earnings date
Q3 20256 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Company Research22 Sep 2025
Moody's: Shaping Global Credit
Explore Moody's evolution from publishing manuals to becoming a giant in credit ratings, guiding issuers, investors, and regulators worldwide.
)
Edge19 Sep 2025
American Express: An Empire of Plastic
How history, brand, and structure have steadily built American Express' moat, and why Warren Buffett still calls it a one-of-a-kind business.
Frequently asked questions
Camurus is a pharmaceutical company that develops and commercializes long-acting treatments for serious and chronic conditions. The company specializes in proprietary drug delivery technologies, particularly its FluidCrystal system, which is designed to provide extended drug release through subcutaneous or intramuscular injection. Camurus focuses on areas such as opioid dependence, pain management, oncology, and endocrinology, aiming to improve treatment adherence and patient outcomes. Its product portfolio includes both commercialized therapies and development-stage programs across multiple therapeutic areas. The company is headquartered in Lund, Sweden, and its shares are listed on the Stockholm Stock Exchange.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage